A New Marker for Tamoxifen Resistance in ER-Dependent Breast Cancer
Abstract
While the significance of the protein kinase AKT expression lactivity in human breast cancer has become increasingly evident, consistent alterations of a specific isoform have not been well documented, A specific isoform of AKT may be preferentially activated or activated proteins may have different substrate preferences, providing a therapeutic opportunity to target a particular isoform. Previously, we have demonstrated a cross-talk between the growth factor and estrogen transduction pathways, converging in the ErbB2/PI 3-K/AKT1 signaling.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 01, 2005
- Accession Number
- ADA446369
Entities
People
- Adriana Stoica
Organizations
- Georgetown University